31 Mar 2023
Long-term safety of common ADHD medication for children and adolescents, global team finds
Long-term use of methylphenidate, the most commonly prescribed medication for treating ADHD, does not increase the risk of adverse developmental and psychiatric outcomes in children and adolescents, an international research team has found. The findings have led experts to argue for the drug’s inclusion on a global Essential Medicines list.